A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/55 (2006.01) A61M 1/14 (2006.01) A61M 1/16 (2006.01) A61M 1/34 (2006.01) A61M 1/36 (2006.01)
Patent
CA 2356440
There is provided the use of a low molecular weight thrombin inhibitor for the manufacture of a medicament for the treatment by dialysis, particularly haemodialysis, of a patient in need of such treatment, in which the thrombin inhibitor is provided in the dialysing solution, as well as dialysing solutions and concentrates including low molecular weight thrombin inhibitors, such as melagatran.
La présente invention concerne l'utilisation d'un inhibiteur de thrombine de faible masse moléculaire pour la fabrication d'un médicament accompagnant les traitements dialytiques, s'agissant plus particulièrement d'hémodialyse, dans le cas d'un patient justiciable d'un tel traitement. Le procédé consiste à utiliser l'inhibiteur thrombinique dans la solution de dialyse. L'invention concerne également des solutions et concentrés de dialyse incluant un inhibiteur de thrombine de faible masse moléculaire tel que le mélagatrane.
Astrazeneca Ab
Fetherstonhaugh & Co.
LandOfFree
New dialysis method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with New dialysis method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New dialysis method will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2018481